Remove 2023 Remove Communication Remove Immunization
article thumbnail

Five Things For Pharmacists To Know About Measles in 2025

IDStewardship

People born before 1957 are considered immune, because the vaccine was given to such a large percentage of that population. The COVID-19 pandemic is credited for disrupting routine measles immunization services in many countries, which is likely contributing to a recent resurgence in cases globally. The recommended dose is 0.5

Vaccines 214
article thumbnail

The 2023-2024 Flu Season: What Pharmacists Need to Know

Digital Pharmacist

As we gear up for the upcoming flu season of 2023-2024, it’s important to reflect on the lessons of the previous year , and understand how the coming year may look different. 2023 Flu Vaccination Changes As we look at the 2023-2024 flu season, what’s new for this year?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Market Your Pharmacy with a 2023 Health Awareness Calendar

Digital Pharmacist

Creating a 2023 health awareness calendar this year is a great way to market your pharmacy while promoting patient health. . World Immunization Week: April 24-30. National Immunization Awareness Month. Promoting Your 2023 Health Awareness Calendar. National Cancer Prevention Month. National Kidney Month. UV Safety Month.

article thumbnail

Pharmacy Star Ratings Changes Coming in 2023

Digital Pharmacist

Food and Drug Administration (FDA) announced its approval of the Boostrix vaccine, commonly known as Tdap (combination of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis) for immunization administration during the third trimester of pregnancy to prevent pertussis in infants younger than two months of age. Background.

article thumbnail

Grace’s 3 Years as an NF2 BioSolutions UK PhD Student

NF2 BioSolutions

I have enjoyed every moment, and I have made the most of all the opportunities to pass my way through the University of Manchester, NF2 research community and the Charity, all of whom have driven this research forward. Although VS and meningioma are both brain tumours in NF2, their immune cells act differently. So what have we found?

article thumbnail

Science Summarised: NF2 and Sporadic Vestibular Schwannoma

NF2 BioSolutions

[Image Description] Paper header for paper titled “The comparable tumour microenvironment in sporadic and NF2-related schwannomatosis vestibular schwannoma” by Gregory et al 2023, published in Brain Communications. PAPER AIMS To investigate NF2 and sporadic vestibular schwannoma, we compared: their “ gene expression ” (i.e

article thumbnail

Adam’s 3 Years as an NF2 BioSolutions PhD Student

NF2 BioSolutions

As some of you may know, the focus of my PhD was to explore role of the immune system in VS, particularly a subset of immune cells known as T-cells. Along with PD-1, these T-cells expressed several other inhibitory molecules, all of which are targetable with immunotherapy-based drugs, like immune checkpoint blockade.